An engineered periosteum for efficient delivery of rhBMP-2 and mesenchymal progenitor cells during bone regeneration
Romero-Torrecilla, J.A.; Lamo-Espinosa, J.M.; Ripalda-Cemboráin, P.; López-Martínez, T.; Abizanda, G.; Riera-Álvarez, L.; de Galarreta-Moriones, S.R.; López-Barberena, A.; Rodríguez-Flórez, N.; Elizalde, R.; Jayawarna, V.; Valdés-Fernández, J.; de Anleo, M.E.-G.; Childs, P.; de Juan-Pardo, E.; Salmeron-Sanchez, M.; Prósper, F.; Muiños López, Emma; Granero-Moltó, F.
Identificadores
Identificadores
Visualización ou descarga de ficheiros
Visualización ou descarga de ficheiros
Data de publicación
2023Título da revista
npj Regenerative Medicine
Tipo de contido
Artigo
Resumo
During bone regeneration, the periosteum acts as a carrier for key regenerative cues, delivering osteochondroprogenitor cells and crucial growth factors to the injured bone. We developed a biocompatible, 3D polycaprolactone (PCL) melt electro-written membrane to act as a mimetic periosteum. Poly (ethyl acrylate) coating of the PCL membrane allowed functionalization, mediated by fibronectin and low dose recombinant human BMP-2 (rhBMP-2) (10-25 ?g/ml), resulting in efficient, sustained osteoinduction in vitro. In vivo, rhBMP-2 functionalized mimetic periosteum demonstrated regenerative potential in the treatment of rat critical-size femoral defects with highly efficient healing and functional recovery (80%-93%). Mimetic periosteum has also proven to be efficient for cell delivery, as observed through the migration of transplanted periosteum-derived mesenchymal cells to the bone defect and their survival. Ultimately, mimetic periosteum demonstrated its ability to deliver key stem cells and morphogens to an injured site, exposing a therapeutic and translational potential in vivo when combined with unprecedentedly low rhBMP-2 doses.
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution 4.0 International (CC BY 4.0)











